Type:Notice
Citation:90 FR 9731
Reading Time:about a minute or two
Scottsdale Research Institute has applied to the Drug Enforcement Administration (DEA) to become a bulk manufacturer of certain controlled substances. This registration is intended to support the production of these substances for clinical trials and research purposes. The public can submit comments or objections electronically through the Federal eRulemaking Portal by April 21, 2025. The DEA requires comments to be submitted online and will provide a tracking number to confirm submission.
Simple Explanation
Scottsdale Research Institute wants to make certain special substances for important scientific tests, and people can tell the big decision-makers what they think about it before April 21, 2025.